APA
Revilla-Monsalve C., Zendejas-Ruiz I., Islas-Andrade S., Báez-Saldaña A., Palomino-Garibay M. A., Hernández-Quiróz P. M. & Fernandez-Mejia C. (20070212). Biotin supplementation reduces plasma triacylglycerol and VLDL in type 2 diabetic patients and in nondiabetic subjects with hypertriglyceridemia. : Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
Chicago
Revilla-Monsalve Cristina, Zendejas-Ruiz Iván, Islas-Andrade Sergio, Báez-Saldaña Armida, Palomino-Garibay Miguel Angel, Hernández-Quiróz Pedro Martín and Fernandez-Mejia Cristina. 20070212. Biotin supplementation reduces plasma triacylglycerol and VLDL in type 2 diabetic patients and in nondiabetic subjects with hypertriglyceridemia. : Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
Harvard
Revilla-Monsalve C., Zendejas-Ruiz I., Islas-Andrade S., Báez-Saldaña A., Palomino-Garibay M. A., Hernández-Quiróz P. M. and Fernandez-Mejia C. (20070212). Biotin supplementation reduces plasma triacylglycerol and VLDL in type 2 diabetic patients and in nondiabetic subjects with hypertriglyceridemia. : Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
MLA
Revilla-Monsalve Cristina, Zendejas-Ruiz Iván, Islas-Andrade Sergio, Báez-Saldaña Armida, Palomino-Garibay Miguel Angel, Hernández-Quiróz Pedro Martín and Fernandez-Mejia Cristina. Biotin supplementation reduces plasma triacylglycerol and VLDL in type 2 diabetic patients and in nondiabetic subjects with hypertriglyceridemia. : Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 20070212.